Ozempic

Novo Nordisk A/S (NYSE:NVO), the maker of ‘Miracle‘ weight loss drugs Ozempic and Wegovy, is reportedly set to construct a large-scale manufacturing facility in Dublin as demand surges for its weight-loss drugs. What Happened: The pharmaceutical giant from Denmark has put forth plans...

Congressman Bernie Sanders (I-Vt.) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs. In his newest battle, Sanders is taking on the growing popularity of weight-loss drugs and diabetes...

What Happened: Jim Cramer outlined fresh investment prospects on Monday, revolving around the growing demand for GLP-1 drugs, typically administered for diabetes and obesity treatment. As reported by CNBC, investors initially expressed concerns about these drugs’ market impact. However, with...

How important it is to have the latest blockbuster in your product portfolio. The pharmaceuticals industry has displayed this over and again in recent years — getting a Covid vaccine to market during the pandemic, and now tackling the obesity epidemic. Those with obesity drugs already on the market...

Novo Nordisk A/S (NYSE: NVO) plans to limit starter kit supplies of Ozempic (semaglutide) in Europe and reduce the distribution of Victoza (liraglutide), aiming to bolster Ozempic's production, which has experienced a significant surge in demand.  Victoza and Ozempic belong to...

Tema, the exchange-traded fund platform, has launched a healthcare ETF focused on companies that research and treat cardiovascular disease and conditions associated with obesity and diabetes, including Novo Nordisk, maker of the blockbuster diet drug Ozempic. The Tema Cardiovascular and Metabolics...

The FDA has approved Eli Lilly And Co's (NYSE: LLY) Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.  The active...

The year 2023 has had its share of themes and innovations, but perhaps none have been as impactful as the rise of artificial intelligence. The choice of “AI” as the word of the year by a leading dictionary is unsurprising to many, given its enduring relevance. What Happened: Much like...

GLP-1s, or weight-loss drugs like Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy, are helping millions of Americans manage their weight and diabetes. But what if you could get some of the benefits of Ozempic and Wegovy just by altering your diet? Semaglutide, the primary ingredient in...

British singer-songwriter Robbie Williams has attributed his significant weight loss to a drug similar to Ozempic, revealing that his weight gain has grave impacts on his mental health. Robbie admitted in a new interview that gaining weight can be “shockingly catastrophic” to ...

Ozempic, Novo Nordisk’s (NYSE: NVO) diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such as liposuction and bariatric surgeries. Some companies are already seeing the impact of...

Prescription weight loss drugs Ozempic, Wegovy and Mounjaro have dominated headlines in 2023 with increased interest and the impact being discussed by food and drink companies. Here's a look at the consumer segments that might be driving the enthusiasm and demand for these GLP-1 drugs. What...

As obesity rates climb worldwide, so does the demand for weight-loss medications like Novo Nordisk's (NYSE: NVO) Ozempic and Eli Lilly And Company's (NYSE: LLY) Mounjaro.  This heightened demand, however, has spurred a troubling rise in counterfeit drugs,...

Swiss food conglomerate, Nestlé SA (OTC:NSRGY), announced plans to create products that pair with popular weight-loss medications like Ozempic, Wegovy, and Mounjaro. As per a Forbes report, this move comes amid concerns about the potential impacts these appetite-suppressing...

With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platforms. Morgan Stanley (NYSE: MS) outlined various industries that are set to be impacted by the public...